MAXCYTE, INC. Quarterly Selling and Marketing Expense in USD from Q2 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Maxcyte, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2020 to Q2 2024.
- Maxcyte, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $6.62M, a 2.81% increase year-over-year.
- Maxcyte, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $28.2M, a 24.8% increase year-over-year.
- Maxcyte, Inc. annual Selling and Marketing Expense for 2023 was $27M, a 44.6% increase from 2022.
- Maxcyte, Inc. annual Selling and Marketing Expense for 2022 was $18.7M, a 43.5% increase from 2021.
- Maxcyte, Inc. annual Selling and Marketing Expense for 2021 was $13M, a 56.1% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)